Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of a metabolic agent in Japan (details not disclosed)
jRCT2080225366Phase 2Completed
- Sponsor
- IQVIA
- Start
- Aug 2020
01
Overview
Phase 2 trial (2 arms), sponsored by IQVIA. Started Aug 2020; status: completed.
Beyond the preview
Go deeper on jRCT2080225366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080225366.